Dysport 500 Units

Maximize Clinic ROI and Patient Satisfaction with Dysport 500 Units

Buy Dysport 500 Units online to optimize your clinic’s profitability and provide patients with a highly responsive, globally recognized neuromodulator. Developed by Ipsen and backed by Galderma, Dysport (abobotulinumtoxinA) is a premium, FDA-approved Botulinum Toxin Type A engineered for rapid tissue integration. This 500-unit high-capacity vial is meticulously designed for high-turnover medical spas and advanced injectors who require massive cost-efficiency for large-volume aesthetic corrections and broad-area therapeutic applications.

Advanced Diffusion and Rapid Clinical Onset

Dysport is structurally distinct from other botulinum toxins due to its smaller molecular weight profile regarding its complexing proteins. Clinically, this gives abobotulinumtoxinA a slightly wider “field of effect” or diffusion radius once injected. For the treating physician, this wider spread is a massive advantage when treating broad areas like the forehead or treating axillary hyperhidrosis, as it requires fewer injection points to achieve complete, smooth coverage. Furthermore, Dysport is universally praised by patients and practitioners alike for its incredibly rapid onset, frequently presenting visible muscle relaxation much faster than traditional neurotoxins.

Clinical Indications for 500-Unit High-Capacity Vials

The expanded 500 Speywood Unit capacity is strategically sized for heavy-dose, macro-muscle applications and clinics treating multiple patients back-to-back:

• Broad Forehead Rhytides: Utilizing Dysport’s superior diffusion to achieve smooth, comprehensive relaxation across wide horizontal forehead lines with fewer needle sticks.
• Masseter Contouring (Jawline Slimming): Delivering heavy, symmetrical relaxation to oversized masseter muscles for lower facial contouring and severe bruxism.
• Primary Axillary Hyperhidrosis: Administering high-volume, localized intradermal blocks to overactive sweat glands where the wide diffusion creates a seamless therapeutic blanket.
• Severe Glabellar Lines: Rapidly softening deep vertical frown lines between the eyebrows for a fast, refreshed aesthetic.

Efficacy Timeline: Fast Response and Extended Longevity

Dysport holds a highly coveted reputation in the aesthetics industry for patients who need quick, reliable results before major social events:

• Initial Onset: Visual relaxation of the targeted muscles frequently begins to present incredibly fast, often within 24 to 48 hours post-treatment.
• Peak Result: Complete neuromodulatory integration and maximum cosmetic smoothing achieve total stability at approximately 10 to 14 days.
• Duration: The therapeutic aesthetic benefits remain dynamically active for an average of 3 to 5 months, with some clinical studies showing extended efficacy depending on the dosage and patient metabolism.

Technical Specifications

Reconstitution Protocol & Dilution Chart for Dysport 500U

Reconstitution must be executed under strict sterile clinical conditions by qualified healthcare professionals using preservative-free 0.9% Sodium Chloride (Normal Saline). Important Medical Note: Dysport is measured in proprietary Speywood Units (sU). These units are NOT interchangeable 1:1 with other botulinum toxin products (e.g., Botox, Xeomin).

Introduce the normal saline slowly into the vial. Gently swirl the vial in a smooth circular motion until the white lyophilized powder completely dissolves into a crystal-clear liquid solution. Do not agitate or shake vigorously.

• For 10 sU per 0.05 mL dosing: Add 2.5 mL of sterile saline.
• For 20 sU per 0.1 mL dosing: Add 2.5 mL of sterile saline.
• For 50 sU per 0.1 mL dosing: Add 1.0 mL of sterile saline.

Frequently Asked Questions (FAQ)

Professional Medical Procurement Disclaimer: Dysport 500 Units is a prescription-only, high-potency professional aesthetic medication restricted exclusively to licensed healthcare professionals, dermatologists, and certified injectors. Botoderm assumes absolutely no clinical or legal liability for adverse reactions, complications, dosing errors, or loss of product efficacy due to unauthorized self-administration, home use, or poor storage handling post-delivery.